Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy

TY - JOUR

T1 - Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy

AU - Alseraihy, Amal

AU - McGrath, Eoin

AU - Niederwieser, Dietger

AU - Chabannon, Christian

AU - Szer, Jeff

AU - Mohty, Mohamad

AU - Kharfan-Dabaja, Mohamed A

AU - Orchard, Kim

AU - Schwartz, Joseph

AU - Rasheed, Walid

AU - Koh, Mickey

AU - Kröger, Nicolaus

AU - Kodera, Yoshihisa

AU - Fakih, Riad El

AU - Worel, Nina

AU - Manson, Lynn

AU - Rintala, Tuula

AU - Tabakhi, Abdelghani

AU - Savani, Bipin

AU - Gergis, Usama

AU - Sureda, Anna

AU - Eldridge, Paul W

AU - Yakoub-Agha, Ibrahim

AU - Hamadani, Mehdi

AU - Weisdorf, Daniel

AU - Greinix, Hildegard

AU - Aljurf, Mahmoud

N1 - Copyright © 2022. Published by Elsevier Inc.

PY - 2022/8

Y1 - 2022/8

N2 - Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increased demands on healthcare resources. Although improving quality is an integral component of healthcare strategic planning, drivers of quality may be variable, and there is logical debate as to what drives quality in HSCT. Moreover, HSCT programs differ in structure and availability of resources, which drive the type of transplantations provided and determine what is affordable and/or economically feasible. The complexity of HSCT procedures with involvement of different stakeholders necessitates not only regulatory frameworks, but also robust quality systems to ensure consistent standards, demonstrate transparency for regulators, and define what quality means within the HSCT program. In an era of escalating healthcare complexity and heightened fiscal responsibility, transparency and accountability, accreditation contributes to ensuring that care meets the highest standards and can serve as a risk mitigation strategy. Quality management has become an indispensable tool for the management of a complex medical intervention such as HSCT. It allows the transplantation team to monitor its activities and identify areas for continuous improvement. The Worldwide Network for Blood and Marrow Transplantation invited a group of international experts in HSCT and quality management to work on providing a summary document about the key elements in quality and accreditation in HSCT and highlight the foremost challenges of implementing them, with a special focus on low- and middle-income economies.

AB - Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increased demands on healthcare resources. Although improving quality is an integral component of healthcare strategic planning, drivers of quality may be variable, and there is logical debate as to what drives quality in HSCT. Moreover, HSCT programs differ in structure and availability of resources, which drive the type of transplantations provided and determine what is affordable and/or economically feasible. The complexity of HSCT procedures with involvement of different stakeholders necessitates not only regulatory frameworks, but also robust quality systems to ensure consistent standards, demonstrate transparency for regulators, and define what quality means within the HSCT program. In an era of escalating healthcare complexity and heightened fiscal responsibility, transparency and accountability, accreditation contributes to ensuring that care meets the highest standards and can serve as a risk mitigation strategy. Quality management has become an indispensable tool for the management of a complex medical intervention such as HSCT. It allows the transplantation team to monitor its activities and identify areas for continuous improvement. The Worldwide Network for Blood and Marrow Transplantation invited a group of international experts in HSCT and quality management to work on providing a summary document about the key elements in quality and accreditation in HSCT and highlight the foremost challenges of implementing them, with a special focus on low- and middle-income economies.

KW - Accreditation

KW - Bone Marrow

KW - Cell- and Tissue-Based Therapy

KW - Health Facilities

KW - Hematopoietic Stem Cell Transplantation/methods

U2 - 10.1016/j.jtct.2022.04.003

DO - 10.1016/j.jtct.2022.04.003

M3 - SCORING: Review article

C2 - 35413459

VL - 28

SP - 455

EP - 462

JO - TRANSPL CELL THER

JF - TRANSPL CELL THER

SN - 2666-6375

IS - 8

ER -